GetTopicDetailResponse(id=a77f1118200e, topicName=厄達(dá)替尼, introduction=厄達(dá)替尼, content=卡介苗 非肌層浸潤性膀胱癌 厄達(dá)替尼, image=null, comments=0, allHits=1140, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Mar 02 09:44:41 CST 2024, time=2024-03-02, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=478661, tagList=[TagDto(tagId=478661, tagName=厄達(dá)替尼)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2271176, encodeId=c56a22e1176b1, content=<a href='/topic/show?id=843a85e9421' target=_blank style='color:#2F92EE;'>#膀胱癌#</a> <a href='/topic/show?id=a77f1118200e' target=_blank style='color:#2F92EE;'>#厄達(dá)替尼#</a>, objectTitle=Cancer Res：武漢大學(xué)肖行遠(yuǎn)等團(tuán)隊(duì)研究發(fā)現(xiàn)MCHA與厄達(dá)替尼的合成致死療法可能成為提高膀胱癌靶向治療應(yīng)答率的新策略, objectType=article, longId=881810, objectId=b44e881810aa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241212/1733998939042_8538692.png, objectUrl=/article/show_article.do?id=b44e881810aa, replyNumber=0, likeNumber=29, createdTime=2025-06-27, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b44e881810aa, moduleTitle=Cancer Res：武漢大學(xué)肖行遠(yuǎn)等團(tuán)隊(duì)研究發(fā)現(xiàn)MCHA與厄達(dá)替尼的合成致死療法可能成為提高膀胱癌靶向治療應(yīng)答率的新策略, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b44e881810aa)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2234669, encodeId=02ff2234669d1, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=ccf410109188' target=_blank style='color:#2F92EE;'>#食管癌#</a> <a href='/topic/show?id=a77f1118200e' target=_blank style='color:#2F92EE;'>#厄達(dá)替尼#</a>, objectTitle=厄達(dá)替尼亞洲人群數(shù)據(jù)：FGFR變異的晚期膽管癌、NSCLC和食管癌治療療效如何？, objectType=article, longId=849434, objectId=f9eb84943499, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720670560286_5579292.jpg, objectUrl=/article/show_article.do?id=f9eb84943499, replyNumber=0, likeNumber=92, createdTime=2024-11-01, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f9eb84943499, moduleTitle=厄達(dá)替尼亞洲人群數(shù)據(jù)：FGFR變異的晚期膽管癌、NSCLC和食管癌治療療效如何？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f9eb84943499)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190546, encodeId=ad71219054667, content=<a href='/topic/show?id=8fcf3648eca' target=_blank style='color:#2F92EE;'>#卡介苗#</a> <a href='/topic/show?id=2e2399635a4' target=_blank style='color:#2F92EE;'>#非肌層浸潤性膀胱癌#</a> <a href='/topic/show?id=a77f1118200e' target=_blank style='color:#2F92EE;'>#厄達(dá)替尼#</a>, objectTitle=Ann. Oncol | 厄達(dá)替尼在經(jīng)卡介苗治療的高危非肌層浸潤性膀胱癌中的應(yīng)用, objectType=article, longId=815534, objectId=8014815534a9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240301/1709302082430_6145188.jpg, objectUrl=/article/show_article.do?id=8014815534a9, replyNumber=0, likeNumber=117, createdTime=2024-03-02, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8014815534a9, moduleTitle=Ann. Oncol | 厄達(dá)替尼在經(jīng)卡介苗治療的高危非肌層浸潤性膀胱癌中的應(yīng)用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8014815534a9)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-03-02發(fā)表于上海
